Literature DB >> 13651495

The treatment of myotonia: a controlled clinical trial.

P LEYBURN, J N WALTON.   

Abstract

Entities:  

Keywords:  MYOTONIA/therapy; PREDNISONE/therapeutic use; PROCAINE AMIDE/therapeutic use; QUININE/therapeutic use

Mesh：

Substances：

Year:  1959        PMID： 13651495     DOI： 10.1093/brain/82.1.81

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  18 in total

1.  Some muscular manifestations of hypothyroidism.

Authors:  J WILSON; J N WALTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1959-11       Impact factor: 10.154

2.  The effect of changes in serum potassium upon myotonia.

Authors:  P LEYBURN; J N WALTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-05       Impact factor: 10.154

3.  Myotonia Dystrophia: A Review of 17 Cases.

Authors:  B Slatt
Journal:  Can Med Assoc J       Date:  1961-07-29       Impact factor: 8.262

4.  Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.

Authors:  E L Logigian; W B Martens; R T Moxley; M P McDermott; N Dilek; A W Wiegner; A T Pearson; C A Barbieri; C L Annis; C A Thornton; R T Moxley
Journal:  Neurology       Date:  2010-05-04       Impact factor: 9.910

5.  Lupus-like syndrome, with persistent immunological abnormalities, related to procainamide therapy.

Authors:  T P Anastassiades; J A Miliiken
Journal:  Can Med Assoc J       Date:  1972-08-19       Impact factor: 8.262

6.  Physiological characterisation of the "warm up" effect of activity in patients with myotonic dystrophy.

Authors:  R G Cooper; M J Stokes; R H Edwards
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-09       Impact factor: 10.154

Review 7.  Guidelines on clinical presentation and management of nondystrophic myotonias.

Authors:  Bas C Stunnenberg; Samantha LoRusso; W David Arnold; Richard J Barohn; Stephen C Cannon; Bertrand Fontaine; Robert C Griggs; Michael G Hanna; Emma Matthews; Giovanni Meola; Valeria A Sansone; Jaya R Trivedi; Baziel G M van Engelen; Savine Vicart; Jeffrey M Statland
Journal:  Muscle Nerve       Date:  2020-05-27       Impact factor: 3.217

8.  A comparative study of disopyramide and procainamide in the treatment of myotonia in myotonic dystrophy.

Authors:  M Finlay
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-05       Impact factor: 10.154

9.  Nifedipine in the treatment of myotonia in myotonic dystrophy.

Authors:  R Grant; D L Sutton; P O Behan; J P Ballantyne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-02       Impact factor: 10.154

10.  Nondystrophic myotonia: challenges and future directions.

Authors:  Jaya R Trivedi; Stephen C Cannon; Robert C Griggs
Journal:  Exp Neurol       Date:  2013-12-18       Impact factor: 5.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.